Stemline Therapeutics Stock Price (NASDAQ:STML)

Add to My Stocks
$10.4 $0.6 (5.45%) STML stock closing price Jan 20, 2017 (Closing)
Stemline Therapeutics
20 JAN 2017
amigobulls logo
STML hand_up
STML vs S&P 500
Closing Price: Jan 20, 2017
$10.4 ( -5.45%)
S&P 500
2271.3 ( 0.34%)
52 Week Price Range
1 Year Return: 115.69%
Q3 Growth*
Profitable ?
net image
2016 Q3 Net Loss
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

Stemline Therapeutics Snapshot Video

12 5 2

STML Stock Details

Prev Close* : $11.00
Market Cap:
Day Low: $10.28
52 Week Low: $3.88
Open: $10.4
Volume: 2326448
Day High: $10.85
52 Week High: $14.60

Latest Stock Market News

Latest Articles

Stemline Therapeutics News - From Partners

STML Stockcharts

View STML PE ratio, PS ratio stocks charts and compare with peers.
STML Chart
Note: Compare Stemline Therapeutics stock price history with the index and industry peers.

Stemline Therapeutics Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Stemline Therapeutics Financial Ratios

Asset Turnover

STML Industry Peers

Company Price Change (%)
Nicox (NICXF)10.30 (0%)
Compugen (CGEN)4.60.05 (1.08%)
Karyopharm Therapeutics (KPTI)10.390.08 (0.76%)
Celgene (CELG)112.660.96 (0.84%)
Agenus (AGEN)3.770.04 (1.05%)
Immunocellular Therapeutics (IMUC)2.390.03 (1.27%)
Seattle Genetics (SGEN)58.790.48 (0.81%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
NewLink Genetics (NLNK)11.330.54 (5%)
Argos Therapeutics (ARGS)5.050.2 (4.12%)
Halozyme Therapeutics (HALO)11.50.42 (3.79%)
BioDelivery Sciences (BDSI)1.90.05 (2.7%)
Osiris Therapeutics (OSIR)5.040.13 (2.65%)
VIVUS (VVUS)1.190.03 (2.59%)
Amarin (AMRN)2.950.07 (2.43%)
Top gainers from Medical-Biomed-Genetics industry
* As of Jan 21, 2017
CompanyPriceChange (%)
Pluristem Therapeutics (PSTI)1.150.25 (17.86%)
Puma Biotech (PBYI)32.253.25 (9.15%)
Sangamo BioSciences (SGMO)3.650.3 (7.59%)
Five Prime Therapeutics (FPRX)43.52.58 (5.6%)
Stemline Therapeutics (STML)10.40.6 (5.45%)
Sarepta Therapeutics (SRPT)32.661.57 (4.59%)
Inovio Pharma (INO)6.280.3 (4.56%)
Top losers from Medical-Biomed-Genetics industry
* As of Jan 21, 2017

Stemline Therapeutics Financial Statements

income statement20152014201320122011
Net Sales Or Revenues0.65M0.33M0.07M--
Net Income-37.24M-28.82M-24.19M-6.27M-2.75M
Total Operating Expense38.27M29.32M24.04M6.46M2.7M
view Stemline Therapeutics Inc income statement
balance sheet20152014201320122011
Total Assets98.21M60.49M85.28M5.02M6.45M
Total Liabilities10.1M5.08M5.65M7.53M3.24M
Shareholders Equity88.11M55.41M79.62M-2.5M3.2M
view Stemline Therapeutics Inc balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities6M-1.71M2.66M1.53M0.6M
Net Cash From (Used By) Operating Activities-25.58M-25.71M-16.11M-4.12M-1.93M
Increase (Decrease) In Prop Plant And Equipment-0.01M--0.46M--
view Stemline Therapeutics Inc cashflow statement

Stemline Therapeutics Inc Stock News - Partner Headlines

Stemline Therapeutics Stock Message Board

Stemline Therapeutics stock lost -5.45 %, and the last close price as of 20 Jan, 2017 is 10.4 for STML stock. Looking at Stemline Therapeutics market capitalization, which currently stands at 210.75M, we can say that STML stock is a Micro cap stock. A value investor must look at the fundamentals of a stock, and perform Stemline Therapeutics valuation, even though in the short-term sentiment and current breaking news might affect Stemline Therapeutics stock price.

For recognizing and analyzing the real performance of Stemline Therapeutics stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. 2326448 STML shares were traded yesterday, and Stemline Therapeutics stock chart shows that the STML stock quote hit a day high of 10.85 and day low of 10.28. One can observe stock price trends and check for volatility by checking Stemline Therapeutics stock price history.